ARTICLE | Finance
Lucky No. 7
Frazier tailors seventh biotech fund to fit in LPs' $250-$400M sweet spot
October 7, 2013 7:00 AM UTC
In raising its seventh fund, Frazier Healthcare took the advice of LPs who suggested bigger is not always better. The fund closed last week at $377 million, overshooting its $300 million target but coming in well below the $600 million fund Frazier closed in 2007.
LPs are decreasing their venture exposure. But rather than exiting the space, they are getting more selective, according to Frazier's James Topper...